Skip to main content
뒤로

Principles of Disease, Pathogenicity, Immunity, and Immunological Applications

스터디 가이드 - 스마트 노트

자료에 맞춘 맞춤형 노트, 핵심 정의, 예시, 맥락을 확장해 제공합니다.

Principles of Disease and Epidemiology

Key Definitions in Pathology

  • Pathology: The scientific study of disease, including its causes, development, and effects on the body.

  • Etiology: The study of the cause of a disease.

  • Infection: The invasion and multiplication of microorganisms in body tissues, which may cause disease.

  • Disease: An abnormal state in which the body is not functioning normally due to infection or other causes.

Human Microbiome Acquisition

  • Normal Microbiota: Microorganisms that colonize the body without causing disease under normal conditions.

  • Transient Microbiota: Microbes present for a short period; may be removed by host defenses or competition.

  • Acquisition: The human microbiome is acquired during and after birth, influenced by delivery mode, environment, and diet.

Symbiotic Relationships

  • Commensalism: One organism benefits, the other is unaffected. Example: Staphylococcus epidermidis on skin.

  • Mutualism: Both organisms benefit. Example: Escherichia coli in the gut synthesizes vitamins for the host.

  • Parasitism: One organism benefits at the expense of the other. Example: Pathogenic bacteria causing disease.

  • Microbial Antagonism: Normal microbiota prevent colonization by pathogens through competition and production of inhibitory substances.

Opportunistic Microorganisms

  • Opportunistic Pathogens: Normally harmless but can cause disease when host defenses are compromised or in unusual locations.

  • Communicable Disease: Spread from one host to another (e.g., influenza).

  • Noncommunicable Disease: Not spread from host to host (e.g., tetanus).

Koch’s Postulates

  • 1. The microorganism must be found in all cases of the disease.

  • 2. It must be isolated and grown in pure culture.

  • 3. The cultured microorganism must cause disease when introduced into a healthy host.

  • 4. It must be reisolated from the experimentally infected host.

  • Exceptions: Some pathogens cannot be cultured, have multiple causes, or cause different diseases in different hosts.

Incidence vs. Prevalence

  • Incidence: Number of new cases in a population during a specific time period.

  • Prevalence: Total number of cases (new and existing) at a given time.

Categories of Disease Severity

  • Acute: Develops rapidly, short duration (e.g., influenza).

  • Chronic: Develops slowly, persists (e.g., tuberculosis).

  • Subacute: Intermediate between acute and chronic.

  • Latent: Pathogen inactive for a time, then activates (e.g., herpesvirus).

Herd Immunity

  • Occurs when a large portion of a population is immune, reducing disease spread.

  • Develops through vaccination or previous infection.

Predisposing Factors for Disease

  • Age, gender, genetics, climate, fatigue, lifestyle, chemotherapy, and other illnesses.

Patterns and Durations of Disease

  • Incubation Period: Time between infection and symptom onset.

  • Prodromal Period: Early, mild symptoms.

  • Period of Illness: Most severe symptoms.

  • Period of Decline: Symptoms subside.

  • Period of Convalescence: Recovery and return to normal.

Reservoirs and Carriers

  • Reservoir: Continual source of infection.

  • Carrier: Human reservoir who harbors pathogens without symptoms.

  • Types: Human (e.g., carriers of typhoid), animal (e.g., bats for rabies), nonliving (e.g., soil for tetanus).

  • Zoonoses: Diseases transmitted from animals to humans (e.g., Zika, rabies).

Methods of Disease Transmission

  • Contact Transmission: Direct (person-to-person), indirect (fomites), droplet (coughing, sneezing).

  • Vehicle Transmission: Via water, food, or air.

  • Vector Transmission: Mechanical (passive, e.g., flies), biological (active, e.g., mosquitoes).

Healthcare-Associated Infections (HAIs)

  • Infections acquired in healthcare settings.

  • Important due to increased morbidity, mortality, and costs.

  • Compromised Host: Individual with impaired resistance to infection.

  • Prevention: Hand hygiene, sterilization, isolation, and surveillance.

Emerging Infectious Diseases

  • New or increasing in incidence.

  • Reasons: Microbial evolution, antibiotic misuse, climate change, travel, and animal-human contact.

  • Example: Zika virus spread in Central America due to vector presence and climate; limited spread in USA due to vector control and climate differences.

Epidemiology

  • Study of disease occurrence, distribution, and control in populations.

  • Morbidity: Incidence of disease.

  • Mortality: Deaths from disease.

  • Notifiable Diseases: Diseases required by law to be reported to authorities.

Microbial Mechanisms of Pathogenicity

Portals of Entry

  • Microorganisms enter the host via mucous membranes (respiratory, gastrointestinal, genitourinary), skin, or parenteral route (injury).

ID50 and LD50

  • ID50: Infectious dose for 50% of the population.

  • LD50: Lethal dose for 50% of the population.

  • Potency Comparison: Lower LD50 indicates higher potency. For example, botulinum toxin (0.03 ng/kg) is more potent than Salmonella toxin (12 mg/kg).

Adherence to Host Cells

  • Microbes use adhesins (e.g., fimbriae, glycocalyx) to attach to host receptors (e.g., mannose).

  • Drugs targeting host receptors may block pathogen adherence.

Virulence Factors

  • Capsules: Prevent phagocytosis (e.g., Streptococcus pneumoniae).

  • M Proteins: Resist phagocytosis (e.g., Streptococcus pyogenes).

  • Cell Wall Components: Aid in evasion of host defenses.

  • Enzymes: Coagulases (clot formation), kinases (clot breakdown), hyaluronidases (tissue penetration), collagenases (collagen breakdown).

  • Some bacteria can produce multiple enzymes simultaneously.

Antigenic Variation

  • Pathogens alter surface antigens to evade immune response (e.g., influenza virus).

  • Annual influenza vaccination is needed due to frequent antigenic changes.

Membrane Ruffling

  • Bacteria induce host cell cytoskeleton changes to facilitate entry (e.g., Salmonella).

Evasion of Host Defenses

  • Examples: S. pneumoniae (capsule), S. aureus (protein A), L. monocytogenes (intracellular growth), M. tuberculosis (resists digestion), Rickettsia (intracellular).

Toxigenicity and Direct Damage

  • Toxigenicity: Ability to produce toxins.

  • Direct Damage: Pathogen damages host cells directly during invasion.

Endotoxins vs. Exotoxins

Property

Exotoxins

Endotoxins

Chemical Nature

Proteins

Lipopolysaccharide (LPS)

Source

Gram-positive & Gram-negative bacteria

Gram-negative bacteria

Heat Stability

Unstable

Stable

Toxicity

High

Low

Effect

Specific

General (fever, shock)

Immunity

Stimulates antitoxin production

Weak immune response

  • Exotoxins are generally more lethal due to high potency.

Food Infection vs. Food Intoxication

  • Food Infection: Ingestion of pathogens that grow in the host.

  • Food Intoxication: Ingestion of preformed toxins.

Role of Plasmids and Lysogeny

  • Plasmids may carry toxin or antibiotic resistance genes.

  • Lysogeny can convert nonpathogenic E. coli into a pathogen by introducing toxin genes.

Cytopathic Effects

  • Visible effects of viral infection on host cells (e.g., cell lysis, inclusion bodies).

Portals of Exit

  • Pathogens exit via respiratory tract, gastrointestinal tract, genitourinary tract, skin, or blood.

Antibiotic Treatment and Endotoxins

  • Antibiotics may lyse Gram-negative bacteria, releasing endotoxins and causing persistent symptoms (e.g., fever, low blood pressure).

Innate Immunity: Nonspecific Defenses

Innate vs. Adaptive Immunity

  • Innate Immunity: Nonspecific, present at birth, rapid response.

  • Adaptive Immunity: Specific, develops after exposure, slower response.

Toll-like Receptors (TLRs)

  • Proteins on host cells that recognize pathogen-associated molecular patterns (PAMPs) and activate immune responses.

Physical and Chemical Barriers

  • Skin: Physical barrier, acidic pH, lysozyme in sweat.

  • Mucous Membranes: Trap microbes, contain antimicrobial substances.

  • Eyes: Tears with lysozyme.

  • Digestive Tract: Stomach acid, digestive enzymes.

  • Respiratory Tract: Mucus, cilia, coughing, sneezing.

Role of Normal Microbiota

  • Compete with pathogens, produce inhibitory substances (antagonism).

  • Commensalism: One benefits, other unaffected.

Leukocyte Classification

  • Granulocytes: Neutrophils, eosinophils, basophils.

  • Agranulocytes: Monocytes, lymphocytes (T cells, B cells, NK cells), dendritic cells.

  • Monocytes: Differentiate into macrophages, phagocytosis.

  • Neutrophils: Phagocytosis, first responders to infection.

Differential Blood Count

  • Measures proportions of different white blood cells (WBCs).

  • Eight types: Neutrophils, eosinophils, basophils, monocytes, lymphocytes (T, B, NK), dendritic cells, mast cells.

Lymphatic System

  • Returns interstitial fluid to blood, filters pathogens via lymph nodes.

Phagocytosis

  • Phagocytes ingest and destroy microbes.

  • Resting Macrophages: Inactive, become active upon infection.

  • Wandering Macrophages: Move through tissues to sites of infection.

  • TLRs aid in adherence and activation of phagocytes.

Inflammation

  • Redness, swelling, pain, heat due to vasodilation and increased permeability.

  • Mediators: Kinins, prostaglandins, leukotrienes.

  • Purpose: Contain infection, remove debris, repair tissue.

Fever

  • Caused by pyrogens (e.g., endotoxins).

  • Benefits: Inhibits microbes, increases immune activity.

Complement System

  • Group of proteins that enhance immune responses.

  • Activation cascade amplifies response.

  • Three pathways: Classical, alternative, lectin.

Interferons and Siderophores

  • Interferons: Proteins that inhibit viral replication.

  • Siderophores: Bacterial proteins that scavenge iron from the host.

Antimicrobial Peptides (AMPs)

  • Produced by many organisms (e.g., humans, plants, insects).

  • Tested for antimicrobial activity using in vitro assays.

Nonspecific Antimicrobial Substances

  • Mucus: Traps microbes (found in respiratory, digestive tracts).

  • Lysozyme: Breaks down bacterial cell walls (found in tears, saliva).

  • Acidic pH: Inhibits microbial growth (found in stomach, skin).

Adaptive Immunity: Specific Defenses

Adaptive vs. Innate Immunity

  • Adaptive immunity is specific and has memory; vaccination induces adaptive immunity.

Humoral vs. Cellular Immunity

  • Humoral Immunity: Mediated by B cells and antibodies.

  • Cellular Immunity: Mediated by T cells.

Cytokines and Related Molecules

  • Cytokines: Signaling proteins in immune responses.

  • Interleukins: Mediate communication between leukocytes.

  • Chemokines: Attract immune cells to infection sites.

  • Interferons: Inhibit viral replication.

  • TNF: Inflammation and apoptosis.

  • Hematopoietic Cytokines: Stimulate blood cell formation.

Antigens, Epitopes, and Haptens

  • Antigen: Substance that elicits an immune response.

  • Epitope: Specific region of antigen recognized by antibodies.

  • Hapten: Small molecule that becomes antigenic when attached to a carrier.

Antibody Structure and Function

  • Y-shaped proteins with variable regions binding epitopes.

  • Classes: IgG, IgM, IgA, IgD, IgE (each with distinct functions).

  • Variable region differs among B cells.

T-Dependent vs. T-Independent Antigens

  • T-Dependent: Require T cell help for B cell activation.

  • T-Independent: Activate B cells without T cell help.

Plasmocytes and Memory Cells

  • Plasmocytes (plasma cells) produce antibodies but do not generate memory cells.

Clonal Selection Theory

  • B cells with specific receptors proliferate upon antigen exposure, producing plasma and memory cells.

Antigen-Antibody Reactions

  • Neutralization, agglutination, precipitation, opsonization, complement activation.

Antigen-Presenting Cells (APCs)

  • Cells (e.g., dendritic cells, macrophages) that present antigens to T cells.

Apoptosis

  • Programmed cell death, important for removing infected or abnormal cells.

Natural Killer (NK) Cells

  • Destroy infected or cancerous cells without prior sensitization.

Primary vs. Secondary Immune Response

  • Primary: First exposure, slower, lower antibody levels.

  • Secondary: Subsequent exposure, faster, higher antibody levels due to memory cells.

Acquisition of Antibodies

  • Natural infection, passive transfer (e.g., maternal antibodies), vaccination.

Thymus and Adaptive Immunity

  • Absence of thymus impairs T cell development; adaptive immunity is compromised.

Practical Applications of Immunology

Vaccination and Vaccine Types

  • Vaccination is the most effective method for controlling viral diseases.

  • Types: Attenuated (live, weakened), inactivated, subunit, nucleic acid (DNA, mRNA), recombinant vector.

  • Attenuated Vaccines: Strong, long-lasting immunity but risk in immunocompromised individuals.

  • Nucleic Acid/Recombinant Vector Vaccines: Safe, rapid production, no risk of infection.

  • DNA/mRNA vaccines are faster to produce and do not require animal cells.

Adjuvants

  • Substances added to vaccines to enhance immune response.

Specificity and Sensitivity

  • Specificity: Ability to detect only the target antigen or antibody.

  • Sensitivity: Ability to detect small amounts of antigen or antibody.

Immunological Tests

  • Agglutination Tests: Detect antigen-antibody reactions by visible clumping.

  • Direct Agglutination: Detects antigens on cells.

  • Indirect Agglutination: Uses particles coated with antigen or antibody.

  • ELISA (Enzyme-Linked Immunosorbent Assay): Detects antigens or antibodies using enzyme-linked indicators.

  • Direct ELISA: Detects antigens in a sample.

  • Indirect ELISA: Detects antibodies in a sample.

Pearson Logo

스터디 프렙